- Home
- IDR vs TKNO Comparison
IDR vs TKNO Comparison
Compare IDR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDR
- TKNO
- Stock Information
- Founded
- IDR 1996
- TKNO 1996
- Country
- IDR United States
- TKNO United States
- Employees
- IDR N/A
- TKNO 173
- Industry
- IDR Precious Metals
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- IDR Basic Materials
- TKNO Health Care
- Exchange
- IDR Nasdaq
- TKNO Nasdaq
- Market Cap
- IDR 378.0M
- TKNO 256.9M
- IPO Year
- IDR N/A
- TKNO 2021
- Fundamental
- Price
- IDR $25.51
- TKNO $4.69
- Analyst Decision
- IDR Strong Buy
- TKNO
- Analyst Count
- IDR 1
- TKNO 0
- Target Price
- IDR $17.50
- TKNO N/A
- AVG Volume (30 Days)
- IDR 475.0K
- TKNO 323.1K
- Earning Date
- IDR 08-07-2025
- TKNO 08-07-2025
- Dividend Yield
- IDR N/A
- TKNO N/A
- EPS Growth
- IDR 57.55
- TKNO N/A
- EPS
- IDR 0.64
- TKNO N/A
- Revenue
- IDR $30,496,328.00
- TKNO $38,923,000.00
- Revenue This Year
- IDR $21.91
- TKNO $8.73
- Revenue Next Year
- IDR $5.47
- TKNO $16.53
- P/E Ratio
- IDR $39.96
- TKNO N/A
- Revenue Growth
- IDR 59.64
- TKNO 11.40
- 52 Week Low
- IDR $9.58
- TKNO $3.75
- 52 Week High
- IDR $27.39
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- IDR 71.70
- TKNO 49.37
- Support Level
- IDR $23.11
- TKNO $4.39
- Resistance Level
- IDR $27.39
- TKNO $4.97
- Average True Range (ATR)
- IDR 1.54
- TKNO 0.42
- MACD
- IDR 0.56
- TKNO 0.06
- Stochastic Oscillator
- IDR 83.41
- TKNO 45.52
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.